D1 Capital Partners 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
D1 Capital Partners disclosed 41 US equity positions worth $6.5bn in its Q1 2025 13F filing. The largest position was CART at 13.8% of the reported book, followed by ENTG and SCHW. Against the Q4 2024 filing, it opened 18 new positions, added to 8 and reduced 14 among the top 41 holdings.
What did D1 Capital Partners own in Q1 2025? Top 41 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | CART MAPLEBEAR INC | Consumer Cyclical | 13.8% | $899.6m | 22,551,414 | 0% | held |
| 2 | ENTG ENTEGRIS INC | Technology | 5.7% | $369.6m | 4,224,574 | 53% | added |
| 3 | SCHW SCHWAB CHARLES CORP | Financial Services | 5.2% | $341.0m | 4,355,608 | – | new |
| 4 | XPO XPO INC | Industrials | 5.0% | $328.4m | 3,052,186 | 50% | added |
| 5 | BAC BANK AMERICA CORP | Financial Services | 4.7% | $304.6m | 7,299,000 | – | new |
| 6 | AKX ANSYS INC | 4.2% | $273.6m | 864,345 | 247% | added | |
| 7 | ELV ELEVANCE HEALTH INC | Healthcare | 3.9% | $251.6m | 578,411 | -28% | reduced |
| 8 | CNM CORE & MAIN INC | Industrials | 3.7% | $238.9m | 4,945,680 | – | new |
| 9 | PM PHILIP MORRIS INTL INC | Consumer Defensive | 3.7% | $238.9m | 1,505,033 | -59% | reduced |
| 10 | RCL ROYAL CARIBBEAN GROUP | Consumer Cyclical | 3.5% | $229.0m | 1,114,713 | -29% | reduced |
| 11 | APP APPLOVIN CORP | Communication Services | 3.2% | $209.3m | 790,000 | 64% | added |
| 12 | ALK ALASKA AIR GROUP INC | Industrials | 3.1% | $203.3m | 4,130,000 | – | new |
| 13 | RDDT REDDIT INC | Communication Services | 2.9% | $187.6m | 1,788,000 | – | new |
| 14 | PRMB PRIMO BRANDS CORPORATION | Consumer Defensive | 2.8% | $185.4m | 5,224,266 | – | new |
| 15 | AMZN AMAZON COM INC | Consumer Cyclical | 2.8% | $181.0m | 951,234 | 132% | added |
| 16 | APO APOLLO GLOBAL MGMT INC | Financial Services | 2.7% | $174.8m | 1,276,209 | – | new |
| 17 | CP CANADIAN PACIFIC KANSAS CITY | Industrials | 2.5% | $163.4m | 2,327,000 | – | new |
| 18 | BDX BECTON DICKINSON & CO | Healthcare | 2.4% | $153.9m | 672,000 | – | new |
| 19 | COF CAPITAL ONE FINL CORP | Financial Services | 2.2% | $145.4m | 811,000 | 67% | added |
| 20 | LINE LINEAGE INC | 2.2% | $144.1m | 2,457,061 | -35% | reduced | |
| 21 | SNPS SYNOPSYS INC | Technology | 2.2% | $143.5m | 334,700 | 32% | added |
| 22 | CRL CHARLES RIV LABS INTL INC | Healthcare | 1.8% | $117.0m | 777,489 | -17% | reduced |
| 23 | CRS CARPENTER TECHNOLOGY CORP | Industrials | 1.7% | $111.7m | 616,644 | – | new |
| 24 | GEHC GE HEALTHCARE TECHNOLOGIES I | Healthcare | 1.5% | $100.9m | 1,249,584 | -64% | reduced |
| 25 | NU NU HLDGS LTD | Financial Services | 1.5% | $100.4m | 9,803,000 | -34% | reduced |
| 26 | USFD US FOODS HLDG CORP | Consumer Defensive | 1.3% | $86.5m | 1,322,000 | – | new |
| 27 | SGI SOMNIGROUP INTERNATIONAL INC | Consumer Cyclical | 1.2% | $80.0m | 1,336,567 | – | new |
| 28 | CVNA CARVANA CO | Consumer Cyclical | 1.2% | $77.4m | 370,000 | – | new |
| 29 | TOL TOLL BROTHERS INC | Consumer Cyclical | 1.1% | $72.9m | 690,000 | -18% | reduced |
| 30 | BBWI BATH & BODY WORKS INC | Consumer Cyclical | 1.0% | $66.7m | 2,200,000 | -22% | reduced |
| 31 | KRC KILROY RLTY CORP | Real Estate | 0.9% | $61.8m | 1,887,000 | – | new |
| 32 | LEN LENNAR CORP | Consumer Cyclical | 0.8% | $53.8m | 468,433 | -30% | reduced |
| 33 | CDNS CADENCE DESIGN SYSTEM INC | Technology | 0.8% | $50.4m | 198,000 | – | new |
| 34 | CLH CLEAN HARBORS INC | Industrials | 0.6% | $38.0m | 193,022 | – | new |
| 35 | AFRM AFFIRM HLDGS INC | Financial Services | 0.6% | $37.1m | 820,000 | – | new |
| 36 | INTC INTEL CORP | Technology | 0.5% | $32.8m | 1,443,000 | – | new |
| 37 | AMAT APPLIED MATLS INC | Technology | 0.5% | $29.7m | 205,000 | 13% | added |
| 38 | LRCX LAM RESEARCH CORP | Technology | 0.4% | $29.3m | 403,000 | -4% | reduced |
| 39 | QSR RESTAURANT BRANDS INTL INC | Consumer Cyclical | 0.1% | $6.2m | 92,833 | -95% | reduced |
| 40 | WRBY WARBY PARKER INC | Healthcare | 0.1% | $4.7m | 257,306 | -95% | reduced |
| 41 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.1% | $3.4m | 978,652 | -56% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.